Ecovyst Inc (ECVT)vsLinde plc Ordinary Shares (LIN)
ECVT
Ecovyst Inc
$12.85
-0.62%
BASIC MATERIALS · Cap: $1.43B
LIN
Linde plc Ordinary Shares
$507.90
-0.40%
BASIC MATERIALS · Cap: $229.28B
Smart Verdict
WallStSmart Research — data-driven comparison
Linde plc Ordinary Shares generates 4257% more annual revenue ($34.65B vs $795.36M). LIN leads profitability with a 20.4% profit margin vs -8.0%. LIN trades at a lower P/E of 32.9x. LIN earns a higher WallStSmart Score of 62/100 (C+).
ECVT
Hold42
out of 100
Grade: D
LIN
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-31.8%
Fair Value
$8.85
Current Price
$12.85
$4.00 premium
Margin of Safety
-70.2%
Fair Value
$298.47
Current Price
$507.90
$209.43 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 50.2% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Mega-cap, among the largest globally
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 28.5%
Areas to Watch
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
ROE of -11.0% — below average capital efficiency
Earnings declined 28.6%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : ECVT
The strongest argument for ECVT centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 50.2% demonstrates continued momentum.
Bull Case : LIN
The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.5%.
Bear Case : ECVT
The primary concerns for ECVT are Market Cap, P/E Ratio, Return on Equity. A P/E of 77.0x leaves little room for execution misses.
Bear Case : LIN
The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
ECVT profiles as a hypergrowth stock while LIN is a mature play — different risk/reward profiles.
ECVT carries more volatility with a beta of 1.06 — expect wider price swings.
ECVT is growing revenue faster at 50.2% — sustainability is the question.
LIN generates stronger free cash flow (898M), providing more financial flexibility.
Bottom Line
LIN scores higher overall (62/100 vs 42/100), backed by strong 20.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ecovyst Inc
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
Ecovyst Inc. (ECVT) is a key innovator in the industrial technology sector, specializing in advanced catalysts and materials designed to enhance sustainability and efficiency across refining, petrochemical, and environmental applications. The company leverages a robust portfolio of proprietary technologies that underscore its dedication to innovation and environmental responsibility. With a clear focus on strategic growth initiatives and a strong foundation of intellectual property, Ecovyst is well-positioned to seize opportunities in the burgeoning market for sustainable industrial practices, aiming for substantial long-term value creation as market dynamics evolve.
Visit Website →Linde plc Ordinary Shares
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Visit Website →Compare with Other SPECIALTY CHEMICALS Stocks
Want to dig deeper into these stocks?